IN2014DN11181A - - Google Patents
Info
- Publication number
- IN2014DN11181A IN2014DN11181A IN11181DEN2014A IN2014DN11181A IN 2014DN11181 A IN2014DN11181 A IN 2014DN11181A IN 11181DEN2014 A IN11181DEN2014 A IN 11181DEN2014A IN 2014DN11181 A IN2014DN11181 A IN 2014DN11181A
- Authority
- IN
- India
- Prior art keywords
- apc
- treat
- individual
- methods
- effective amount
- Prior art date
Links
- 101800004937 Protein C Proteins 0.000 abstract 1
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 abstract 1
- 101800001700 Saposin-D Proteins 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 abstract 1
- 229960000856 protein c Drugs 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012902874A AU2012902874A0 (en) | 2012-07-04 | Treatment of inflammatory skin disorders | |
| PCT/AU2013/000729 WO2014005183A1 (en) | 2012-07-04 | 2013-07-04 | Treatment of inflammatory skin disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN11181A true IN2014DN11181A (cs) | 2015-10-02 |
Family
ID=49881162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN11181DEN2014 IN2014DN11181A (cs) | 2012-07-04 | 2013-07-04 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20150150954A1 (cs) |
| EP (1) | EP2869833B1 (cs) |
| JP (1) | JP6273272B2 (cs) |
| KR (1) | KR102068010B1 (cs) |
| CN (1) | CN104394883B (cs) |
| AU (1) | AU2013286812B2 (cs) |
| BR (1) | BR112015000051A2 (cs) |
| CA (1) | CA2877745C (cs) |
| ES (1) | ES2676422T3 (cs) |
| IN (1) | IN2014DN11181A (cs) |
| RU (1) | RU2662564C2 (cs) |
| WO (1) | WO2014005183A1 (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN11181A (cs) * | 2012-07-04 | 2015-10-02 | Univ Sydney | |
| CN106488773B (zh) | 2014-04-16 | 2020-02-11 | Zz生物技术有限责任公司 | Apc类似物用于创伤愈合的用途 |
| ES2890675T3 (es) * | 2014-04-16 | 2022-01-21 | Zz Biotech Llc | APC para uso en el tratamiento de cicatrices cutáneas anormales |
| EP3527570A4 (en) | 2016-10-14 | 2020-04-15 | Jiangsu Hengrui Medicine Co., Ltd. | FIVE-LINKED HETERARYARYLE CYCLE BRIDGE DERIVATIVE, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF |
| US20210268062A1 (en) * | 2018-06-28 | 2021-09-02 | Novapep Pty Ltd | Inflammatory skin disorder treatment |
| CN109337974B (zh) * | 2018-12-14 | 2022-01-25 | 北京蛋白质组研究中心 | 一种检测银屑病的诊断标志物的试剂及其应用 |
| JP2022516607A (ja) * | 2018-12-26 | 2022-03-01 | ダイレクト バイオロジクス エルエルシー | 皮膚および毛髪障害を治療するための方法および組成物 |
| RU2704322C1 (ru) * | 2019-06-11 | 2019-10-28 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Крем с секретомом мультипотентных мезенхимальных стромальных клеток для коррекции псориазиформного воспаления в эксперименте |
| WO2021011935A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775624A (en) | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
| US5516650A (en) | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
| US4959318A (en) | 1985-06-27 | 1990-09-25 | Zymogenetics, Inc. | Expression of protein C |
| EP0380508A4 (en) | 1987-05-18 | 1991-04-03 | Integrated Genetics, Inc. | Improved protein c molecules and method for making and activating same |
| US5084274A (en) | 1987-11-17 | 1992-01-28 | Scripps Clinic And Research Foundation | Inhibition of arterial thrombotic occlusion or thromboembolism |
| US4981952A (en) | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
| US5093117A (en) | 1989-01-24 | 1992-03-03 | Baxter International Inc. | Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| AT402260B (de) | 1990-08-16 | 1997-03-25 | Immuno Ag | Protein c-hältige pharmazeutische präparation |
| US5571786A (en) | 1990-08-16 | 1996-11-05 | Immuno Aktiengesellschaft | Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation |
| AT397615B (de) * | 1991-05-14 | 1994-05-25 | Immuno Ag | Arzneimittel enthaltend protein c |
| WO1993009807A1 (en) | 1991-11-18 | 1993-05-27 | The Scripps Research Institute | Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels |
| MY110664A (en) | 1992-05-21 | 1999-01-30 | Lilly Co Eli | Protein c derivatives |
| DE4239150A1 (de) | 1992-11-20 | 1994-05-26 | Thomae Gmbh Dr K | O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
| JP3043558B2 (ja) | 1993-10-29 | 2000-05-22 | 財団法人化学及血清療法研究所 | ヒト活性化プロテインｃ調製物及びその製法 |
| WO1995030429A1 (en) | 1994-05-04 | 1995-11-16 | Board Of Trustees Of The University Of Arkansas | Novel ophthalmologic uses of protein c |
| NZ337828A (en) | 1997-04-28 | 2001-06-29 | Lilly Co Eli | Activated protein C formulations having a bulking agent and a salt |
| HUP0001237A3 (en) | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
| DE60144366D1 (de) | 2000-02-04 | 2011-05-19 | Scripps Research Inst | Neuroprotektive, antithrombotische und anti-entzündliche anwendungen von aktiviertem protein c |
| AU2001232799A1 (en) | 2000-02-11 | 2001-08-20 | Eli Lilly And Company | Protein c derivatives |
| CA2404231A1 (en) * | 2000-03-28 | 2001-10-04 | Eli Lilly And Company | Methods of treating diseases with activated protein c |
| WO2002032461A2 (en) | 2000-10-18 | 2002-04-25 | Maxygen Aps | Protein c or activated protein c-like molecules |
| ES2384099T3 (es) * | 2001-06-13 | 2012-06-29 | The University Of Sydney | Proteína C para cicatrización de heridas |
| WO2004041296A2 (en) * | 2002-11-06 | 2004-05-21 | Novo Nordisk A/S | Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| SI1477166T1 (sl) | 2003-04-28 | 2006-12-31 | Biofrontera Bioscience Gmbh | Uporaba riluzola, kombiniranega s primernimi pomoznimi in dodatnimi snovmi, za zdravljenje bolezni,za katere je znacilna hiperproliferacija keratinocitov, se zlasti nevrodermitisa in psoriaze |
| WO2005007820A2 (en) | 2003-07-08 | 2005-01-27 | The Scripps Research Institute | Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| US9192657B2 (en) | 2003-07-08 | 2015-11-24 | The Scripps Research Institute | Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity |
| EP1688161A1 (en) * | 2004-11-02 | 2006-08-09 | Switch Biotech Aktiengesellschaft | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
| US20080293631A1 (en) * | 2005-01-07 | 2008-11-27 | Christopher John Jackson | Treatment for Autoimmune and Inflammatory Conditions |
| US20070224150A1 (en) * | 2005-03-24 | 2007-09-27 | Yongji Chung | Growth factor for hair and skin treatment |
| US20100297099A1 (en) | 2005-06-24 | 2010-11-25 | Lars Otto Uttenthal | Airway Administration of Activated Protein C in Inflammatory Conditions Affecting the Respiratory Tract |
| CA2617532A1 (en) * | 2005-08-04 | 2007-02-15 | Sirtris Pharmaceuticals, Inc. | Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| GR1005700B (el) * | 2006-09-01 | 2007-10-22 | (40%) ����� �������� | Τροπος αντιμετωπισης της 1ης φασης του εγκαυματοσσε μη σηπτικους ασθενεις με συνεχη ενδοφλεβια χορηγηση ενεργοποιημενης πρωτεινης-c για 48 ωρες με στοχο τη μειωση της τελικης εγκαυματικης βλαβης καιαυξηση της ταχυτητας επουλωσης κατα τα πρωτα επτα μετεγκαυματικα 24ωρα |
| WO2008073603A2 (en) | 2006-10-31 | 2008-06-19 | The Scripps Research Institute | Dosing regimen of activated protein c and variants having reduced anticoagulant activity |
| GB0724231D0 (en) | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
| ES2316312B1 (es) | 2008-06-20 | 2010-02-08 | Ignacio Umbert Millet | Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas. |
| EP2157176A1 (en) * | 2008-08-20 | 2010-02-24 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Protein C Variants |
| CN102448484A (zh) * | 2009-04-01 | 2012-05-09 | 医学研究，基础设施和卫生服务基金的特拉维夫医疗中心 | 调节角质化细胞增生和分化的方法 |
| CN101912450A (zh) * | 2010-09-01 | 2010-12-15 | 吴业刚 | 一种治疗脚气皮炎的中西药组合物及其制备方法 |
| IN2014DN11181A (cs) * | 2012-07-04 | 2015-10-02 | Univ Sydney | |
| CN106488773B (zh) * | 2014-04-16 | 2020-02-11 | Zz生物技术有限责任公司 | Apc类似物用于创伤愈合的用途 |
| ES2890675T3 (es) | 2014-04-16 | 2022-01-21 | Zz Biotech Llc | APC para uso en el tratamiento de cicatrices cutáneas anormales |
| US20210268062A1 (en) * | 2018-06-28 | 2021-09-02 | Novapep Pty Ltd | Inflammatory skin disorder treatment |
-
2013
- 2013-07-04 IN IN11181DEN2014 patent/IN2014DN11181A/en unknown
- 2013-07-04 RU RU2015103510A patent/RU2662564C2/ru active
- 2013-07-04 US US14/409,215 patent/US20150150954A1/en not_active Abandoned
- 2013-07-04 CN CN201380034024.2A patent/CN104394883B/zh active Active
- 2013-07-04 KR KR1020157002889A patent/KR102068010B1/ko active Active
- 2013-07-04 WO PCT/AU2013/000729 patent/WO2014005183A1/en active Application Filing
- 2013-07-04 JP JP2015518732A patent/JP6273272B2/ja active Active
- 2013-07-04 ES ES13812528.1T patent/ES2676422T3/es active Active
- 2013-07-04 EP EP13812528.1A patent/EP2869833B1/en active Active
- 2013-07-04 CA CA2877745A patent/CA2877745C/en active Active
- 2013-07-04 BR BR112015000051A patent/BR112015000051A2/pt not_active Application Discontinuation
- 2013-07-04 AU AU2013286812A patent/AU2013286812B2/en active Active
-
2016
- 2016-11-30 US US15/365,567 patent/US20170080062A1/en not_active Abandoned
-
2020
- 2020-05-21 US US16/880,243 patent/US11617785B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2869833A1 (en) | 2015-05-13 |
| US20170080062A1 (en) | 2017-03-23 |
| KR102068010B1 (ko) | 2020-01-20 |
| ES2676422T3 (es) | 2018-07-19 |
| RU2015103510A (ru) | 2016-08-27 |
| US11617785B2 (en) | 2023-04-04 |
| US20150150954A1 (en) | 2015-06-04 |
| CN104394883B (zh) | 2017-05-31 |
| KR20150036351A (ko) | 2015-04-07 |
| JP6273272B2 (ja) | 2018-01-31 |
| EP2869833B1 (en) | 2018-04-04 |
| CN104394883A (zh) | 2015-03-04 |
| BR112015000051A2 (pt) | 2017-06-27 |
| US20200276281A1 (en) | 2020-09-03 |
| RU2662564C2 (ru) | 2018-07-26 |
| CA2877745C (en) | 2021-11-30 |
| CA2877745A1 (en) | 2014-01-09 |
| AU2013286812B2 (en) | 2017-04-20 |
| AU2013286812A1 (en) | 2015-01-22 |
| WO2014005183A1 (en) | 2014-01-09 |
| EP2869833A4 (en) | 2015-11-18 |
| HK1204573A1 (en) | 2015-11-27 |
| JP2015521632A (ja) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN11181A (cs) | ||
| PH12018500452A1 (en) | Novel modulators and methods of use | |
| PH12015500525A1 (en) | Formulations of enzalutamide | |
| MY167585A (en) | Disposable diaper | |
| GEP201706695B (en) | Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases | |
| BR112014017799A8 (pt) | Compostos inibidores de metaloenzima | |
| MY165759A (en) | Pull-on diaper | |
| UA110813C2 (uk) | Лікування ліподистрофії | |
| IN2014DN00288A (cs) | ||
| IN2014DN00286A (cs) | ||
| EP3674320A3 (en) | Production of heterodimeric proteins | |
| IN2014MN00093A (cs) | ||
| IN2014MN01378A (cs) | ||
| IN2014DN08481A (cs) | ||
| PL2890793T3 (pl) | Wytwarzanie lotnych dienów przez dehydratację enzymatyczną (EC 4.2.1.127) lekkich alkenoli | |
| IN2014DN06792A (cs) | ||
| MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
| MX2016004540A (es) | Tiazolopirimidinonas como moduladores de la actividad de receptores de n-metil-d-aspartato (nmda). | |
| MY167652A (en) | Disposable diaper | |
| MY166103A (en) | Disposable diaper | |
| SG10201703677VA (en) | Methods of treating s. aureus-associated diseases | |
| MX2015006337A (es) | Metodos y composiciones para tratar enfermedades neurodegenerativas. | |
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| GEP201706764B (en) | Quinazolin-thf-amines as pde1 inhibitors | |
| MX2016001195A (es) | Metodos para mejorar sintomas de asma mediante el uso de benralizumab. |